Congenital Muscular Dystrophy
A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...Upcoming Fundraisers
- Minnesota 1/2 Marathon
4 August 2011
St Paul, MN - Ruby's Diner Hosts Cure CMD Fundraiser
19 February 2012
Rolling Hills Estates, CA 90274 - Long Branch 1/2 Marathon
6 May 2012
Long Branch, NJ - Charlie's Take Me Out To The Ballgame!!
8 July 2012
New York - Disneyland 1/2 Marathon
2 September 2012
Anaheim, CA
- Minnesota 1/2 Marathon
CytRx’s Arimoclomol To Be Administered In A Phase 2/Phase 3 Adaptive Clinical Trial In A Subset Of Patients With Familial ALS
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, announced that a Phase 2/3 adaptive clinical trial has commenced to study its molecular chaperone regulator drug candidate arimoclomol in a subset of patients with the inherited or familial form of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.


CureCMD on Twitter
